A Study to Evaluate the Safety and Preliminary Signs of Efficacy of [177Lu]Lu-OncoFAP-23 Alone or in Combination With L19-IL2 as a Treatment of Metastatic FAP-positive Solid Tumors
A Study to Evaluate the Safety and Preliminary Signs of Efficacy of [177Lu]Lu-OncoFAP-23 Alone or in Combination With L19-IL2 as a Treatment of Metastatic FAP-positive Solid Tumors
Recruiting · NCT06640413 · Registry updated 2026-01-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and Preliminary Signs of Efficacy of [177Lu]Lu-OncoFAP-23 Alone or in Combination With L19-IL2 as a Treatment of Metastatic FAP-positive Solid Tumors | classic familial adenomatous polyposis | Recruiting | Phase 1 | 2026-01-14 | NCT06640413 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Philogen S.p.A. | 15 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| ASST Papa Giovanni XXIII Piazza OMS | Bergamo | Italy | 1 |
| Fondazione IRCCS Istituto Nazionale dei Tumori | Milan | Italy | 4 |
| Istituto Europeo di Oncologia | Milan | Italy | 2 |
| Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" Via Mariano Semmola | Naples | Italy | 1 |